A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma (Q33175629)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma |
scientific article |
Statements
1 reference
A novel dosage approach for evaluation of SMANCS [poly-(styrene-co-maleyl-half-n-butylate) - neocarzinostatin] in the treatment of primary hepatocellular carcinoma (English)
1 reference
Seymour LW
1 reference
Olliff SP
1 reference
Poole CJ
1 reference
De Takats PG
1 reference
Orme R
1 reference
Ferry DR
1 reference
Maeda H
1 reference
Konno T
1 reference
Kerr DJ
1 reference
1 June 1998
1 reference
1 reference
1217-1223
1 reference
Identifiers
1 reference